Agree AB. To go from the complications of the existing method of delivery to inhaled versions will mean some serious modifications to the drug. Jf in her earlier interview indicated she was unable to elaborate on the Dep version of Remdesivir ( regards commercialisation) so every possibility.
- Forums
- ASX - By Stock
- SPL
- Trump given Remdesivir....an inferior product to Starpharma's DEP® remdesivir
Trump given Remdesivir....an inferior product to Starpharma's DEP® remdesivir, page-26
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
|
|||||
Last
9.1¢ |
Change
-0.001(0.55%) |
Mkt cap ! $37.52M |
Open | High | Low | Value | Volume |
9.0¢ | 9.1¢ | 9.0¢ | $47.58K | 525.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49413 | 9.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.2¢ | 22000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49413 | 0.091 |
1 | 2750 | 0.090 |
2 | 97420 | 0.089 |
1 | 5000 | 0.088 |
1 | 73255 | 0.087 |
Price($) | Vol. | No. |
---|---|---|
0.092 | 22000 | 1 |
0.093 | 30790 | 3 |
0.094 | 106393 | 1 |
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
SPL (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online